Awaiting the signal: Assessing the efficacy of COVID-19 vaccines

James Capretta and Scott Ganz
Additional contact information
James Capretta: American Enterprise Institute
Scott Ganz: American Enterprise Institute

AEI Economic Perspectives, 2020

Abstract: The global campaign to identify effective vaccines against COVID-19 has entered the final stage of testing for regulatory approval — Phase III trials — for several promising candidates.

Keywords: AEI Economic Perspectives; Coronavirus; COVID-19; Vaccines (search for similar items in EconPapers)
JEL-codes: A (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.aei.org/wp-content/uploads/2020/09/Awaiting-the-Signal.pdf?x91208 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aei:journl:y:2020:id:1008580228

Access Statistics for this article

More articles in AEI Economic Perspectives from American Enterprise Institute Contact information at EDIRC.
Bibliographic data for series maintained by Dave Adams, CIO ().